Levodrix

Levodropropizine, the active ingredient in Levodrix, is an antitussive presented as an oral formulation for oral use. It reduces the frequency and intensity of dry, non‑productive coughs in both adults and children by acting on peripheral cough receptors of the respiratory tract.

GNH USA supplies Levodrix as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, clinics and health‑care institutions worldwide, with a focus on quality assurance, regulatory compliance and reliable logistics. Our distribution network ensures timely delivery across the EU and other markets.

Levodropropizine, marketed as Levodrix, is used to suppress coughs that arise from irritation of the respiratory tract.

Dry cough: reduces the frequency and severity of a dry, tickling cough without producing mucus. Non‑productive cough: alleviates coughing that does not generate sputum, improving comfort. Cough associated with viral respiratory infection: helps control cough symptoms during common colds or mild flu episodes.

Levodropropizine is generally well tolerated, but some patients may experience adverse reactions.

Common Side Effects: - Nausea: mild stomach upset that may resolve with continued use. - Headache: transient mild to moderate headache. - Dizziness: occasional light‑headed sensation. - Abdominal discomfort: mild pain or cramping in the stomach area.

Serious or Rare Side Effects: - Allergic reactions: rash, itching, or swelling that may require medical attention. - Angioedema: swelling of the face, lips, tongue, or throat. - Hepatic dysfunction: signs of liver injury such as jaundice or elevated liver enzymes.

Before using Levodrix, consider the following safety measures.

Assess patient history: verify no known hypersensitivity to levodropropizine. Monitor hepatic function: use caution in patients with liver impairment. Avoid concomitant use with other potent antitussives unless advised. Pregnancy and lactation: consult a healthcare professional before use. Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Levodropropizine may interact with other medicines; review the following categories.

Major Interactions (Avoid): - Concurrent use with monoamine oxidase inhibitors (MAOIs): risk of unknown pharmacodynamic interaction. - Co‑administration with other potent antitussives: may increase risk of excessive cough suppression. - Use with drugs that prolong the QT interval: potential additive cardiac risk.

Moderate Interactions (Monitor Closely): - Combination with sedatives or antihistamines: may enhance drowsiness. - Concurrent use with hepatic enzyme inhibitors: may increase plasma levels of levodropropizine. - Co‑administration with CYP2D6 substrates: possible altered metabolism.